Client was looking for a simple way to help seek FDA approval on Phase 3 drug to enter Phase 4. Problem was to communicate new approach to drug administration. Our user friendly interactive software model allowed decision makers with no health economic background to easily comprehend new drug benefits for patients.
FDA approved new drug for Phase 4 research.